Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors
Clinical trial NCT00007449 · UNKNOWN
Trial details
- NCT number
- NCT00007449
- Sponsor
- Dupont Applied Biosciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.